🇨🇦 PF-07976016 Formulation A in Canada

PF-07976016 Formulation A (pf-07976016-formulation-a) regulatory status in Canada.

Marketing authorisation

PF-07976016 Formulation A in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Canada

Frequently asked questions

Is PF-07976016 Formulation A approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for PF-07976016 Formulation A in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.